Home
About Us
Help and Support
Subscribe
Company Analyst
Financial Analyst
Pipeline Analyst
Archives
Tools
Log In
Print this
efinaconazole (IDP-108, KP-103)
print preview
bookmark
share with colleague
General Information
Company
Kaken Pharmaceutical Co. Ltd.
Description
Topical triazole antifungal
Molecular Target
Mechanism of Action
Latest Stage of Development
Registration
Indication
Onychomycosis
Partner
Valeant Pharmaceuticals International Inc.
Product Summary: Number of Indications in each Phase of Development by Disease Category
More
Product Details
Archive Items are loading
Set Email Alert
dummy
General Information